BaroPace
Issaquah, US · Founded 2020 · Delaware corporation
BaroPace is developing PressurePace, a closed-loop system that adjusts a cardiac pacemaker in response to real-time blood pressure measurements to treat drug-resistant hypertension and common forms of heart failure. The technology is based on the theory and clinical data of Dr. Michael Burnam linking declining heart rate to hypertensive disease and heart failure.
HardwareHealthtechMedical Devices
Founders & leadership
MB
Michael BurnamFounder
JB
Jessica BurnamNamed on SEC filing
Board
EG
Eli GangBoard director
MC
Mike CoyleBoard director
BB
Bradley BurnamBoard director
Competitors · 2
by search overlapNeuroPace4 shared keywordsNeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.
Outpace Bio3 shared keywordsOutpace Bio develops engineered protein technologies and cell therapies to treat solid tumors, focusing on protein design and T cell engineering to improve cancer treatment efficacy and safety.
Companies competing with BaroPace for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements$940K disclosed across 2 rounds · 2020–2024
▶$365KraisedSep 2024 · 5 investors · Other TechnologyRule 506(b)
▶$365KraisedSep 2024 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Eli GangDirector
- Mike CoyleDirector
- Michael BurnamExecutive Officer, Director
- Bradley BurnamDirector
- Offering amount
- $4M
- Amount sold
- $365K
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$575KraisedDec 2020 · 6 investors · Other TechnologyRule 506(b)
▶$575KraisedDec 2020 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael BurnamExecutive Officer, Director, Promoter
- Bradley BurnamDirector
- Eli GangDirector, Promoter
- Jessica BurnamExecutive Officer, Promoter
- Offering amount
- $1.5M
- Amount sold
- $575K
- Sales commissions
- $96.3K
- Placement agents
- Cahn Capital Corp.
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.